Home/Filings/4/0001127602-19-030510
4//SEC Filing

Surface Carol A 4

Accession 0001127602-19-030510

CIK 0001613103other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 4:37 PM ET

Size

22.1 KB

Accession

0001127602-19-030510

Insider Transaction Report

Form 4
Period: 2019-10-11
Surface Carol A
SVP, Chief HR Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2019-10-11$78.00/sh+34,189$2,666,74279,471 total
  • Exercise/Conversion

    Ordinary Shares

    2019-10-11$83.97/sh+17,466$1,466,620121,920 total
  • Tax Payment

    Ordinary Shares

    2019-10-11$107.58/sh72,848$7,836,98849,072 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-10-1134,1891,283 total
    Exercise: $78.00From: 2016-08-03Exp: 2025-08-03Ordinary Shares (34,189 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-10-117,569399 total
    Exercise: $62.76Exp: 2024-07-28Ordinary Shares (7,569 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-10-1117,46617,468 total
    Exercise: $83.97From: 2018-07-31Exp: 2027-07-31Ordinary Shares (17,466 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2019-10-11$62.76/sh+7,569$475,03045,282 total
  • Exercise/Conversion

    Ordinary Shares

    2019-10-11$88.06/sh+24,983$2,200,003104,454 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-10-1124,9838,328 total
    Exercise: $88.06From: 2017-08-01Exp: 2026-08-01Ordinary Shares (24,983 underlying)
Holdings
  • Ordinary Shares

    (indirect: By 401(k))
    1,604
  • Ordinary Shares

    (indirect: NQ Ret Plan Sup)
    546
Footnotes (6)
  • [F1]Between June 18, 2019 and September 30, 2019, the reporting person acquired 2 shares of MDT common stock under the Medtronic NQ Retirement Plan. The information in this report is based on a statement dated as of October 14, 2019.
  • [F2]Between June 18, 2019 and September 30, 2019, the reporting person acquired 7 shares of MDT common stock under the Medtronic 401(k) Plan. The information in this report is based on a statement dated as of October 14, 2019.
  • [F3]This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  • [F4]This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  • [F5]These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
  • [F6]These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant.

Issuer

Medtronic plc

CIK 0001613103

Entity typeother

Related Parties

1
  • filerCIK 0001485966

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:37 PM ET
Size
22.1 KB